All In Biotech

Drug Trial Radar · NCT06635057

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan

A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants With Type 2 Diabetes During Ramadan

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

166

Actual

Start

Oct 11, 2024

Primary completion

Apr 15, 2026

Study completion Apr 15, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Oct 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of the study is to investigate whether tirzepatide can be effectively started before Ramadan and used per label in participants with Type 2 Diabetes during the fasting month.

Conditions

  • Type 2 Diabetes

Interventions

  • TirzepatideDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from Start of Ramadan (SoR)

Locations

29 sites in 2 countries. Site status is shown where the registry gives one.

  • Al Moosa Specialist Hospital

    Al Ahasa, Saudi Arabia

  • National Guard Hospital-King Abdulaziz Medical City

    Alahsa, Saudi Arabia

  • King Abdulaziz Medical City-Jeddah

    Jeddah, Saudi Arabia

  • King Fahad Armed Forces Hospital Jeddah

    Jeddah, Saudi Arabia

  • King Faisal Specialist Hospital & Research Center

    Jeddah, Saudi Arabia

  • Saudi Airlines Medical services

    Jeddah, Saudi Arabia

  • King Faisal Specialist Hospital and Research Center Madina

    Madinah, Saudi Arabia

  • King Saud University

    Riyadh, Saudi Arabia

  • Osepdale Fatebenefratelli e Oftalmico

    Riyadh, Saudi Arabia

  • Al Dallah Hospital

    Riyadh, Saudi Arabia

  • Sulaiman Habib Olaya

    Riyadh, Saudi Arabia

  • Specialized Medical Center Hospital

    Riyadh, Saudi Arabia

  • Dallah Namar Hospital

    Riyadh, Saudi Arabia

  • Dr. Sulaiman Al Habib Hospital As Suwaidi

    Riyadh, Saudi Arabia

  • Dr. Sulaiman Al Habib Medical Complex Arrayan Saudi Arabia

    Riyadh, Saudi Arabia

  • Lifecare Hospital

    Abu Dhabi, United Arab Emirates

  • Tawam Hospital

    Abu Dhabi, United Arab Emirates

  • Imperial College London Diabetes Center

    Abu Dhabi, United Arab Emirates

  • NMC Abu Dhabi

    Abu Dhabi, United Arab Emirates

  • Rashid Centre for Diabetes and Research

    Ajman, United Arab Emirates

  • Thumbay University Hospital

    Ajman, United Arab Emirates

  • Emirates Hospital Dubai

    Dubai, United Arab Emirates

  • Aster Clinics

    Dubai, United Arab Emirates

  • Dubai Diabetes Center

    Dubai, United Arab Emirates

  • Dubai Hospital

    Dubai, United Arab Emirates

  • Medcare Hospital

    Dubai, United Arab Emirates

  • Mediclinic City Hospital

    Dubai, United Arab Emirates

  • Rashid Hospital.

    Dubai, United Arab Emirates

  • Medcare Hospital

    Sharjah city, United Arab Emirates

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.